ASA: Clinical Trials

25 trials of ASA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 active not recruiting, 4 terminated, 2 unknown. 25 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 225Completed 14, Active not recruiting 4, Terminated 4, Unknown 2, Not yet recruiting 1
Phase 33Completed 2, Unknown 1

Follow ASA: new trials by email Literature Review of ASA trials Research Report on ASA

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
Enoxaparin, Aspirin - Pregnancy Related, Protein S Deficiency
Phase 2Not yet recruitingPeking University People's Hospital482024-08-012024-08-01
Outpatient Liquid Aspirin (OLA)
ASA - Covid19
Phase 2UnknownLouisiana State University Health Sciences Center in New Orleans2002021-12-062022-01-03
Effects of Edoxaban on Platelet Aggregation
ASA, Clopidogrel, Edoxaban - SCAD, AMI
Phase 2 / Phase 3CompletedUniversity of Sao Paulo612021-09-142025-04-27
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
EC Aspirin, Radical Prostatectomy, Recombinant Interferon Alfa-2b - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Phase 2Active not recruitingRoswell Park Cancer Institute122019-11-292026-06-09
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet - Melanoma (Skin)
Phase 2CompletedUniversity of Utah952019-07-252022-02-18
Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
Rivaroxaban, ASA - Multiple Myeloma in Relapse, Multiple Myeloma Progression
Phase 2 / Phase 3UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's572019-01-172024-02-29
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
Acetylsalicylic acid, Placebo - Ovarian Cancer Prevention
Phase 2Active not recruitingCanadian Cancer Trials Group1172018-07-242026-09-16
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
Aspirin, Biospecimen Collection, Placebo Administration - Colorectal Adenoma, Colorectal Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)812018-01-162026-11-13
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
ASA, MET, Placebo - Tertiary Prevention in Colon Cancer
Phase 2TerminatedEnte Ospedaliero Ospedali Galliera1602017-03-152025-01-27
The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
AOP2014, Phlebotomies, ASA - Polycythemia Vera
Phase 2CompletedFROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1272017-02-022024-09-19
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
Aspirin 81 mg, Aspirin 325mg - Melanoma (Skin)
Phase 2CompletedUniversity of Utah412016-09-272022-02-18
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
Aspirin, Laboratory Biomarker Analysis, Placebo Administration - Barrett Esophagus, Esophageal Adenocarcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)212016-01-152026-11-13
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Aspirin, Laboratory Biomarker Analysis, Placebo Administration - Tobacco Use Disorder
Phase 2CompletedNational Cancer Institute (NCI)632016-01-132022-06-02
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
Aspirin, Laboratory Biomarker Analysis, Metformin Hydrochloride - Recurrent Prostate Carcinoma, Stage I Prostate Cancer
Phase 2TerminatedRutgers, The State University of New Jersey272015-06-232023-02-08
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Aspirin, Laboratory Biomarker Analysis, Placebo - Current Smoker, Former Smoker
Phase 2CompletedNational Cancer Institute (NCI)1092014-11-212020-05-21
Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
Acetylsalicylic Acid, Placebo - Small for Gestational Age, Infant, Very Low Birth Weight
Phase 2CompletedCHU de Quebec-Universite Laval502014-11-012018-11-09
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
Aspirin, Laboratory Biomarker Analysis, Placebo - Lung Carcinoma, Tobacco Use Disorder
Phase 2CompletedNational Cancer Institute (NCI)542014-06-012018-08-29
The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
Clopidogrel, Ticagrelor, ASA - Acute Coronary Syndrome
Phase 2CompletedMedical University of Vienna892010-10-012014-04-22
Omega-3 and Aspirin in Periodontal Regeneration
Regenerative therapy (omega 3 PUFA plus low dose aspirin), Sugar pill - Periodontal Disease
Phase 2CompletedOctober 6 University402009-11-012010-05-14
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Aspirin, Eflornithine, Laboratory Biomarker Analysis - Adenomatous Polyp
Phase 2CompletedNational Cancer Institute (NCI)1072009-08-202019-09-04

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Colorectal Neoplasms (3)  ·  Tobacco Use Disorder (3)  ·  Colonic Neoplasms (2)  ·  Melanoma (2)  ·  Myocardial Infarction (2)  ·  Prostatic Neoplasms (2)  ·  Acute Coronary Syndrome (1)  ·  Adenocarcinoma Of Esophagus (1)  ·  Adenomatous Polyps (1)  ·  Angina, Stable (1)  ·  Barrett Esophagus (1)  ·  COVID-19 (1)  ·  Coronary Artery Disease (1)  ·  Fetal Growth Retardation (1)  ·  Glioblastoma (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  M.D. Anderson Cancer Center (2)  ·  University of Utah (2)  ·  AstraZeneca (1)  ·  CHU de Quebec-Universite Laval (1)  ·  Canadian Cancer Trials Group (1)  ·  Ente Ospedaliero Ospedali Galliera (1)  ·  FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  Medical University of Vienna (1)  ·  Northwestern University (1)  ·  October 6 University (1)  ·  Peking University People's Hospital (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (16)  ·  Canada (4)  ·  Italy (3)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  China (1)  ·  Egypt (1)  ·  United Kingdom (1)

Top investigators

Douglas Grossman, MD (2)  ·  Amit Oza (1)  ·  Amr M. Elkhouli, ph.D (1)  ·  Andrea De Censi, MD (1)  ·  Bernardo Bonanni (1)  ·  Biren Saraiya, MD (1)  ·  Emmanuel Bujold, MD,MSc,FRCSC (1)  ·  Frank A Sinicrope (1)  ·  Gurkamal S Chatta (1)  ·  Hemant Roy (1)  ·  Linda Garland (1)  ·  Linda L Garland (1)  ·  Mark J Alberts, MD (1)  ·  Martha Louzada, MD (1)  ·  Paul Gurbel, MD (1)

Results publications

PMID 15189396, PMID 15842354, PMID 18094721, PMID 19923168, PMID 20620737, PMID 20637084, PMID 21079055, PMID 22212857, PMID 22409262, PMID 22795280, PMID 23903204, PMID 26503631, PMID 26986753, PMID 29948566, PMID 30514262, PMID 32678292, PMID 33476571, PMID 34582035, PMID 37489818, PMID 38320126, PMID 40034042

NIH funding

P30CA016672 (3), N01CN00031 (2), N01CN00034 (2), P30CA023074 (2), 2015 (1), N01CN00035 (1), N01CN35157 (1), P30CA015083 (1), P30CA060553 (1), P30CA072720 (1), R01CA113681 (1)